全文获取类型
收费全文 | 1659篇 |
免费 | 81篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 61篇 |
妇产科学 | 14篇 |
基础医学 | 228篇 |
口腔科学 | 24篇 |
临床医学 | 197篇 |
内科学 | 486篇 |
皮肤病学 | 40篇 |
神经病学 | 76篇 |
特种医学 | 84篇 |
外科学 | 141篇 |
综合类 | 90篇 |
预防医学 | 96篇 |
眼科学 | 13篇 |
药学 | 103篇 |
中国医学 | 3篇 |
肿瘤学 | 95篇 |
出版年
2023年 | 9篇 |
2022年 | 10篇 |
2021年 | 32篇 |
2020年 | 12篇 |
2019年 | 33篇 |
2018年 | 31篇 |
2017年 | 23篇 |
2016年 | 28篇 |
2015年 | 26篇 |
2014年 | 43篇 |
2013年 | 49篇 |
2012年 | 59篇 |
2011年 | 78篇 |
2010年 | 50篇 |
2009年 | 52篇 |
2008年 | 86篇 |
2007年 | 137篇 |
2006年 | 87篇 |
2005年 | 63篇 |
2004年 | 49篇 |
2003年 | 60篇 |
2002年 | 48篇 |
2001年 | 42篇 |
2000年 | 52篇 |
1999年 | 46篇 |
1998年 | 23篇 |
1997年 | 22篇 |
1996年 | 33篇 |
1995年 | 19篇 |
1994年 | 23篇 |
1993年 | 12篇 |
1992年 | 24篇 |
1991年 | 30篇 |
1990年 | 34篇 |
1989年 | 46篇 |
1988年 | 23篇 |
1987年 | 20篇 |
1986年 | 27篇 |
1985年 | 18篇 |
1984年 | 21篇 |
1983年 | 14篇 |
1981年 | 13篇 |
1980年 | 8篇 |
1979年 | 12篇 |
1978年 | 8篇 |
1976年 | 9篇 |
1975年 | 8篇 |
1974年 | 14篇 |
1972年 | 8篇 |
1966年 | 10篇 |
排序方式: 共有1758条查询结果,搜索用时 62 毫秒
31.
Pabst Andreas Zeller Alexander–N. Sader Robert Wiegner Jörg-Ulf Schneider Matthias Ehrenfeld Michael Hoffmann Jürgen 《Clinical oral investigations》2021,25(6):3853-3860
Clinical Oral Investigations - The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic has created hitherto unknown challenges for healthcare systems and patient care. This study... 相似文献
32.
Johannes Lammer Thomas Zeller Klaus A. Hausegger Philipp J. Schaefer Manfred Gschwendtner Stefan Mueller-Huelsbeck Thomas Rand Martin Funovics Florian Wolf Aljoscha Rastan Michael Gschwandtner Stefan Puchner Ulrich Beschorner Robin Ristl Maria Schoder 《Cardiovascular and interventional radiology》2015,38(3):779-780
33.
Jingzhong Ding Lindsay M. Reynolds Tanja Zeller Christian Müller Kurt Lohman Barbara J. Nicklas Stephen B. Kritchevsky Zhiqing Huang Alberto de la Fuente Nicola Soranzo Robert E. Settlage Chia-Chi Chuang Timothy Howard Ning Xu Mark O. Goodarzi Y.-D. Ida Chen Jerome I. Rotter David S. Siscovick John S. Parks Susan Murphy David R. Jacobs Jr. Wendy Post Russell P. Tracy Philipp S. Wild Stefan Blankenberg Ina Hoeschele David Herrington Charles E. McCall Yongmei Liu 《Diabetes》2015,64(10):3464-3474
34.
Aljoscha Rastan Sebastian Sixt Uwe Schwarzw?lder Thomas Schwarz Ulrich Frank Karlheinz Bürgelin Volker Pochert Elias Noory Pietro Amantea Daniel Gremmelmaier Christian Müller Heinz-Joachim Büttner Franz-Josef Neumann Thomas Zeller 《Journal of endovascular therapy》2008,15(1):83-90
PURPOSE: To report the outcome of a prospective randomized safety and performance trial of 2 access site closure devices versus a wound dressing. METHODS: Between October 2005 and July 2006, 852 consecutive patients (605 men; mean age 67 years) undergoing diagnostic or interventional catheterization procedures thru a 5- or 6-F femoral sheath were randomized to one of the 3 closure methods: a collagen plug device (Angio-Seal), a clip (StarClose), or a wound dressing (D-Stat Dry). The efficacy of the devices was assessed, as well as the complications occurring at the puncture site during the hospital stay. The primary endpoint of the study was the cumulative incidence of access site pseudoaneurysm, major access site bleeding requiring transfusion, access site vascular surgery, or death from all causes. RESULTS: There were no significant differences in baseline characteristics between the 3 treatment groups. The primary endpoint was reached in 20 (7.1%) of 281 patients treated with D-Stat Dry and in 11 (1.9%) of 571 patients treated with the mechanical closure devices (p<0.0001). There was no significant difference among the mechanical closure devices concerning the incidence of the primary endpoint (Angio-Seal 1.1% versus StarClose 2.8%; p = 0.13). CONCLUSION: The collagen plug device had the lowest rates of major and minor access site-related complications after removal of 5- or 6-F femoral sheaths. The difference between the mechanical closure devices concerning the incidence of the primary endpoint did not reach statistical significance. The wound dressing showed significantly higher major and minor complication rates. 相似文献
35.
Alain Putot Marianne Zeller Sophie Perrin Jean-Claude Beer Jack Ravisy Charles Guenancia Raphaël Robert Patrick Manckoundia Yves Cottin 《The American journal of medicine》2018,131(4):422-429.e4
Background
Red blood cell transfusion benefit during acute myocardial infarction remains unclear in the elderly. We aimed to assess the transfusion impact on 1-year mortality in acute myocardial infarction patients aged ≥65 years, according to their age and hemoglobin nadir.Methods
We included 3316 consecutive patients with acute myocardial infarction aged ≥65 years from the “obseRvatoire des Infarctus de Côte d'Or” (RICO) survey. They were categorized according to their hemoglobin nadir (≤8, >8 to ≤10, and >10 g/dL) and age (<80 or ≥80 years).Results
A total of 1906 patients (57%) were 65-79 years old, and 1410 (43%) were aged ≥80 years, of whom 103 (5%) and 145 (10%) patients received red blood cell transfusion, respectively (P < .001). In Cox regression analysis, transfusion was associated with increased 1-year mortality for hemoglobin nadir >10 g/dL but no significant effect for hemoglobin nadir between 8 and 10 g/dL. When hemoglobin nadir was ≤8 g/dL, transfusion did not influence 1-year mortality for younger patients (65-79 years). However, for older patients (≥80 years), transfusion was associated with lower mortality (hazard ratio 0.43 [95% confidence interval, 0.22-0.86], P = .016).Conclusion
Among older patients with acute myocardial infarction, the effect of transfusion was largely dependent on hemoglobin threshold and age. Transfusion was associated with increased 1-year mortality when hemoglobin nadir was >10 g/dL. However, in patients aged ≥80 years with hemoglobin nadir <8 g/dL, transfusion was associated with a 50% reduction in 1-year mortality. 相似文献36.
Postischemic myocardial recovery and oxidative stress status of vitamin C deficient rat hearts 总被引:1,自引:0,他引:1
Vergely C Perrin C Laubriet A Oudot A Zeller M Guilland JC Rochette L 《Cardiovascular research》2001,51(1):89-99
OBJECTIVE: To investigate the role of vitamin C tissue content as a protective agent during myocardial ischemia-reperfusion injury, we have evaluated the postischemic functional recovery and free radical release of osteogenic disorder Shionogi (ODS) inherently scorbutic rat hearts and compared them to healthy Wistar rat hearts. METHODS: Isolated perfused hearts of ODS or Wistar rats underwent 30 min of a global total normothermic ischemia followed by 30 min of reperfusion. The lipid-soluble spin trap alpha-phenyl N-tert-butylnitrone (3 mM) was perfused upstream of the coronary bed. Functional parameters were recorded and samples of coronary effluents were analysed using electron spin resonance spectroscopy to characterise and quantify the amount of radical species released. RESULTS: From the onset of reperfusion, a large and long-lasting release of alkyl/alkoxyl radicals was detected, with a peak value of 29.0+/-3.2 nM obtained after 13 min, which was associated with a persistent contractile dysfunction. However, ODS rat hearts showed a higher myocardial recovery with lower left ventricular end diastolic pressure (44.34+/-1.74 vs. 55.03+/-1.57 mmHg for Wistar), higher recovery of rate pressure product (12.3+/-1.4 vs. 1.9+/-1.7x10(3) mmHg beats/min for Wistar) and shorter duration of contractile abnormalities during reperfusion (3.7+/-1.0 vs. 20.8+/-5.3 min for Wistar). Moreover, free radical release was identical in ODS rat hearts as compared to control Wistar rats. Ascorbic acid tissue content was significantly altered in ODS rats (31.9+/-3.3 vs. 591.0+/-54.9 mmol/g of tissue for Wistar) but superoxide dismutases, glutathion peroxidases and inducible heat shock protein 70 genes were up-regulated. CONCLUSIONS: This study shows that ascorbic-acid-deficient ODS rat hearts are more resistant to an ischemic insult than control Wistar rats, probably through the development of alternative protective defences, like the induction of heat shock proteins. These paradoxical results raise the question of the relative importance of each endogenous antioxidant in the cardiac resistance to ischemia-reperfusion injury. 相似文献
37.
L'Huillier I Cottin Y Touzery C Zeller M Beel JC Fraison M Verges B Louis P Brunotte F Wolf JE 《International journal of cardiology》2003,90(2-3):165-173
Objective: This study was designed to assess the prognostic value of myocardial tomoscintigraphy perfusion imaging after percutaneous coronary intervention (PCI) in asymptomatic diabetic patients. Methods: One hundred and fourteen diabetic patients were followed up during 27±16 (mean±SD) months after the myocardial tomoscintigraphy. PCI-related events were studied after myocardial tomoscintigraphy stress testing and included major cardiac events (MACE) (cardiovascular death, myocardial infarction) and revascularization (bypass surgery or new PCI). Stress myocardial tomoscintigraphy imaging was performed 5±5 months after PCI and ischemia was considered as present if at least 2 contiguous segments were showing reversible defects. Results: Persistent silent ischemia was found in 49/114 (43%) patients. No difference was observed between the two groups for MACE: four among the 65 (6%) non ischemic patients versus 2 among the 49 (4%) ischemic patients (NS). In contrast, 15 (31%) among the ischemic patients and 4 (6%) among the non ischemic patients underwent iterative revascularization (p<0.01). The relative risk of revascularization for patients with significant ischemia was 5.5 versus non ischemic patients (p<0.001). Conclusion: After PCI, in asymptomatic diabetic patients followed by myocardial tomoscintigraphy a high frequency of persistent silent ischemia was found and associated with a high risk for repeat interventional procedure, although no increase in major cardiac events was observed. 相似文献
38.
39.